BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23934379)

  • 1. Photon activation therapy: a Monte Carlo study on dose enhancement by various sources and activation media.
    Bakhshabadi M; Ghorbani M; Meigooni AS
    Australas Phys Eng Sci Med; 2013 Sep; 36(3):301-11. PubMed ID: 23934379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Monte Carlo evaluation of dose enhancement by cisplatin and titanocene dichloride chemotherapy drugs in brachytherapy with photon emitting sources.
    Yahya Abadi A; Ghorbani M; Mowlavi AA; Knaup C
    Australas Phys Eng Sci Med; 2014 Jun; 37(2):327-36. PubMed ID: 24706342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved radial dose function estimation using current version MCNP Monte-Carlo simulation: Model 6711 and ISC3500 125I brachytherapy sources.
    Duggan DM
    Appl Radiat Isot; 2004 Dec; 61(6):1443-50. PubMed ID: 15388146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of photon energy spectra from brachytherapy sources on Monte Carlo simulations of kerma and dose rates in water and air.
    Rivard MJ; Granero D; Perez-Calatayud J; Ballester F
    Med Phys; 2010 Feb; 37(2):869-76. PubMed ID: 20229896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Monte Carlo study on tissue dose enhancement in brachytherapy: a comparison between gadolinium and gold nanoparticles.
    Bahreyni Toossi MT; Ghorbani M; Mehrpouyan M; Akbari F; Sobhkhiz Sabet L; Soleimani Meigooni A
    Australas Phys Eng Sci Med; 2012 Jun; 35(2):177-85. PubMed ID: 22700179
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose enhancement by various nanoparticles in prostate brachytherapy.
    Ghorbani M; Bakhshabadi M; Golshan A; Knaup C
    Australas Phys Eng Sci Med; 2013 Dec; 36(4):431-40. PubMed ID: 24307601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Theoretical and experimental determination of dosimetric characteristics for ADVANTAGE Pd-103 brachytherapy source.
    Meigooni AS; Dini SA; Awan SB; Dou K; Koona RA
    Appl Radiat Isot; 2006 Aug; 64(8):881-7. PubMed ID: 16713277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Technical note: Monte Carlo derivation of TG-43 dosimetric parameters for radiation therapy resources and 3M Cs-137 sources.
    Pérez-Calatayud J; Granero D; Ballester F; Casal E; Cases R; Agramunt S
    Med Phys; 2005 Aug; 32(8):2464-70. PubMed ID: 16193775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The difference of scoring dose to water or tissues in Monte Carlo dose calculations for low energy brachytherapy photon sources.
    Landry G; Reniers B; Pignol JP; Beaulieu L; Verhaegen F
    Med Phys; 2011 Mar; 38(3):1526-33. PubMed ID: 21520864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiation therapy photon beams dose conformation according to dose distribution around intracavitary-applied brachytherapy sources.
    Jurković S; Zauhar G; Faj D; Radojcić DS; Svabić M
    Med Dosim; 2010; 35(1):49-52. PubMed ID: 19931015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Determination of surface dose rate of indigenous (32)P patch brachytherapy source by experimental and Monte Carlo methods.
    Kumar S; Srinivasan P; Sharma SD; Saxena SK; Bakshi AK; Dash A; Babu DA; Sharma DN
    Appl Radiat Isot; 2015 Sep; 103():120-7. PubMed ID: 26086681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Patient-specific Monte Carlo dose calculations for high-dose-rate endorectal brachytherapy with shielded intracavitary applicator.
    Poon E; Williamson JF; Vuong T; Verhaegen F
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1259-66. PubMed ID: 18954720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A simplified analytical dose calculation algorithm accounting for tissue heterogeneity for low-energy brachytherapy sources.
    Mashouf S; Lechtman E; Beaulieu L; Verhaegen F; Keller BM; Ravi A; Pignol JP
    Phys Med Biol; 2013 Sep; 58(18):6299-315. PubMed ID: 23965939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modeling a hypothetical 170Tm source for brachytherapy applications.
    Enger SA; D'Amours M; Beaulieu L
    Med Phys; 2011 Oct; 38(10):5307-10. PubMed ID: 21992348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
    Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
    Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose to tissue medium or water cavities as surrogate for the dose to cell nuclei at brachytherapy photon energies.
    Enger SA; Ahnesjö A; Verhaegen F; Beaulieu L
    Phys Med Biol; 2012 Jul; 57(14):4489-500. PubMed ID: 22722477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of dose distributions around the pulsed-dose-rate Fletcher-Williamson and the low-dose-rate Fletcher-Suit-Delclos ovoids: a Monte Carlo study.
    Price MJ; Gifford KA; Horton J; Lawyer A; Eifel P; Mourtada F
    Phys Med Biol; 2006 Aug; 51(16):4083-94. PubMed ID: 16885626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detailed dose distribution prediction of Cf-252 brachytherapy source with boron loading dose enhancement.
    Ghassoun J; Mostacci D; Molinari V; Jehouani A
    Appl Radiat Isot; 2010 Feb; 68(2):265-70. PubMed ID: 19889549
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of dosimetric characteristics of OptiSeed(TM) a plastic brachytherapy (103)Pd source.
    Wang Z; Hertel NE
    Appl Radiat Isot; 2005 Sep; 63(3):311-21. PubMed ID: 15964196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.